Your Trusted Brand for Over 35 Years

Bronchitis (Acute) References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Treanor JJ, Hayden FG. Viral infections. In: Murray JF, ed. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, PA: Saunders; 2000:929–84.
  2. Smucny J, Fahey T, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2000;(4):CD000245.
  3. Biesalski HK, Frank J. Antioxidants in nutrition and their importance in the anti-oxidative balance in the immune system. Immuno Infekt. 1995;23:166–73.
  4. Gorton HC, Jarvis K. The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manipulative Physiol Ther. 1999 Oct;22(8):530–3.
  5. Hunt C, Chakravorty NK, et al. The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections. Int J Vitam Nutr Res. 1994;64:212–9.
  6. Beharka A, Redican S, et al. Vitamin E status and immune function. Methods Enzymol 1997;282:247–63.
  7. Romieu I. Nutrition and lung health. Int J Tuberc Lung Dis. 2005;9:362–74.
  8. Kupczyk M, Kuna P. Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties. Pol Merkuriusz. 2002;12:248–52.
  9. Reichenberger F, Tamm M. [N-acetylcystein in the therapy of chronic bronchitis]. Pneumologie. 2002 Dec;56(12):793-7.
  10. De Flora A, Grassi C, et al. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J. 1997;10:1535–41.
  11. Schwartz J. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr. 2000 Jan;71(1 Suppl):393S–396S.
  12. Boswellia serrata. Altern Med Rev. 2008;13(2):165–167
  13. Safayhi H, Mack T, Sabieraj J, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 1992 Jun;261(3):1143-6.
  14. Safayhi H, Rall B, et al. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. 1997 Apr;281(1):460-3.
  15. Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci. 2000;66(2):PL21-8.
  16. Maurer HR. Bromelain: Biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58:123–45.
  17. Bernkop-Schnurch A, Giovanelli R, et al. Peroral administration of enzymes: strategies to improve the galenic of dosage forms for trypsin and bromelain. Drug Dev Ind Pharm. 2000 Feb;26(2):115-21.
  18. Hara M, Tanaka K, et al. Immune response to influenza vaccine in healthy adults and the elderly: Association with nutritional status. Vaccine. 2005 Feb 10;23(12):1457–63.
  19. Gay R, Han SN, et al. The effect of vitamin E on secondary bacterial infection after influenza infection in young and old mice. Ann N Y Acad Sci. 2004 Dec;1031:418–21.
  20. Han SN, Meydani SN. Antioxidants, cytokines, and influenza infection in aged mice and elderly humans. J Infect Dis. 2000 Sep;182 Suppl 1:S74-80.
  21. Meydani M. Dietary antioxidants modulation of aging and immune-endothelial cell interaction. Mech Ageing Dev. 1999 Nov;111(2-3):123–32.
  22. Mileva M, Bakalova R, et al. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comp Immunol Microbiol Infect Dis. 2002 Jan;25(1):1–11.
  23. Langkamp-Henken B, Bender BS, et al. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc. 2004 Jan;52(1):3–12.
  24. Girodon F, Lombard M, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: A controlled trial. Ann Nutr Metab. 1997;41(2):98–107.
  25. Girodon F, Galan P, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: A randomized controlled trial. Arch Intern Med. 1999 Apr 12;159(7):748–54.
  26. Beck MA. Antioxidants and viral infections: Host immune response and viral pathogenicity. J Am Coll Nutr. 2001 Oct;20(suppl 5):384S-388S.
  27. Beck MA, Levander OA, et al. Selenium deficiency and viral infection. J Nutr. 2003 May;133(suppl 1):1463S-7S.
  28. Beck MA, Handy J, et al. Host nutritional status: The neglected virulence factor. Trends Microbiol. 2004 Sep;12(9):417–23.
  29. Hulisz D. Efficacy of zinc against common cold viruses: An overview. J Am Pharm Assoc. 2004 Sep-Oct;44(5):594–603.
  30. Prasad AS, Fitzgerald JT, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate: A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000 Aug 15;133(4):245–52.
  31. Marshall S. Zinc gluconate and the common cold: Review of randomized controlled trials. Can Fam Physician. 1998 May;44:1037–42.
  32. Mossad SB, Macknin ML, et al. Zinc gluconate lozenges for treating the common cold: A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996 Jul 15;125(2):81–8.
  33. Kawasaki Y, Isoda H, et al. Inhibition by kappa-casein glycomacropeptide and lactoferrin of influenza virus hemagglutination. Biosci Biotechnol Biochem. 1993 Jul;57(7):1214–5.
  34. Schoen P, Corver J, et al. Inhibition of influenza virus fusion by polyanionic proteins. Biochem Pharmacol. 1997 Apr 4;53(7):995–1003.
  35. Zimecki M, Kocieba M, et al. Immunoregulatory activities of lactoferrin in the delayed-type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology. 2002 Mar;205(1):120–31.
  36. Nishiya K, Horwitz DA. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J Immunol. 1982 Dec;129(6):2519–23.
  37. Waarts BL, Aneke OJ, et al. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate. Virology. 2005 Mar 15;333(2):284–92.
  38. Barak V, Halperin T, et al. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines, I: inflammatory cytokines. Eur Cytokine Netw. 2001 Apr-Jun;12(2):290–6.
  39. Zakay-Rones Z, Varsano N, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995 winter;1(4):361–9.
  40. Hayashi K, Sagesaka YM, et al. Inactivation of human type A and B influenza viruses by tea-seed saponins. Biosci Biotechnol Biochem. 2000 Jan;64(1):184–6.
  41. Iwata M, Toda M, et al. Comparison between black tea and gargles on inhibition of the infectivity of influenza virus [in Japanese]. Kansenshogaku Zasshi. 1997a Nov;71(11):1175–7.
  42. Iwata M, Toda M, et al. Prophylactic effect of black tea extract as gargle against influenza [in Japanese]. Kansenshogaku Zasshi. 1997b Jun;71(6):487–94.
  43. Song JM, Lee KH, et al. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005 Nov;68(2):66–74.
  44. Harris JC, Cottrell SL, et al. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol. 2001 Oct;57(3):282–6.
  45. Kyo E, Uda N, et al. Immunomodulatory effects of aged garlic extract. J Nutr. 2001 Mar;131(suppl 3):1075S–1079S.
  46. Josling P. Preventing the common cold with a garlic supplement: A double-blind, placebo-controlled survey. Adv Ther. 2001 Jul-Aug;18(4):189–93.
  47. Tsai Y, Cole LL, et al. Antiviral properties of garlic: In vitro effects on influenza B, herpes simplex, and coxsackie viruses. Planta Med. 1985 Oct;5:460–1.
  48. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res. 1993 Jan;14(1):1–10.
  49. Maestroni GJ. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv Exp Med Biol. 1999;467:217–26.
  50. Padgett DA, Loria RM, et al. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol. 1997 Sep;78(1-2):203–11.
  51. Padgett DA, Loria RM, et al. Steroid hormone regulation of antiviral immunity. Ann N Y Acad Sci. 2000;917:935–43.
  52. Gombart A, Borregaard N, Koeffler H. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005 Jul;19(9):1067-77.
  53. Choi YS, Hann SK, et al. The effect of cimetidine on verruca plana juvenilis: Clinical trials in six patients. J Dermatol. 1993 Aug;20(8):497–500.
  54. Hueston WJ, Mainous AG III. Acute bronchitis. Am Fam Physician. 1998;57:1270–6.